A Study of Golimumab in Participants With Active Ankylosing Spondylitis

Clinical trial NCT02186873 · COMPLETED

Trial details

NCT number: NCT02186873
Sponsor: Janssen Research & Development, LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Ankylosing Spondylitis

Start date: 2014-09-03
Primary completion: 2015-12-15
Enrollment: 208

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.